Fraser Forum

Health Care

10:21AM
Printer-friendly version
Canada’s chronic health-care problems will likely persist post-pandemic

Canada ranked 25th out of 26 countries for the number of acute care beds.


10:58AM
Printer-friendly version
New regulations will ultimately deprive Canadians of new medicines

Drug developers are more likely to invest in research and development if prices for their medicines are high.


9:17AM
Printer-friendly version
Throne speech acknowledges wait times—but provinces remain bound by Ottawa

For elective surgery, 99 per cent of Germans reported waiting less than four months compared to 62 per cent of Canadians.


9:40AM
Printer-friendly version
Before adding new programs, Ottawa should consider what Canadians already pay for health care

The Trudeau government will likely expand the scope of our public health-care system and Canadian families will pay even more for public health care every year.


1:11PM
Printer-friendly version
New review rules—the impact on drug access in Canada

In 2017, the federal government introduced new regulations for the drug review board.


12:02PM
Printer-friendly version
Proposed ‘drug price’ changes threaten access for Canadian patients

Advanced clinical trials in Canada, which were consistent between 2015 and 2019, decreased by 26 per cent in 2020.


11:39AM
Printer-friendly version
Delayed drug approvals in Canada—here’s why

New drugs are approved later in Canada than in the United States and European Union.


10:38AM
Printer-friendly version
Approving new drugs in Canada—a 30-year review

Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.


Subscribe to the Fraser Institute

Get the latest news from the Fraser Institute on the latest research studies, news and events.